Advertisement
Screener

Jazz Pharmaceuticals plc (JAZZ) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)

Jazz Pharmaceuticals plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)

Jazz Pharmaceuticals plc (JAZZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) of 680.00% for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.

Discontinued › Notes › Compensation Related Costs

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm · last filed 2012-02-28

  • Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, vested and expected to vest, exercisable, weighted average remaining contractual term (deprecated 2012-01-31) for fiscal 2011 was 680.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) 12 month
2011-12-31680.00%
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
Viatris Inc (VTRS)United States$20.008B-0.00
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28